𝗜𝗡𝗩𝗔-𝗔𝗜-𝗛𝗘𝗥𝗔𝗟𝗗 - 🎨 Canva Launches Craft, Its First In-House Image-Generation Model
𝗜𝗡𝗩𝗔-𝗔𝗜-𝗛𝗘𝗥𝗔𝗟𝗗 📰 𝗔𝗜 𝗡𝗘𝗪𝗦 1. 🧬 Pathos AI Partners With Bristol Myers Squibb and Tempus AI for Drug Discovery 📰 WHAT HAPPENED !! Pathos AI announced a collaboration with Bristol Myers Squibb and Tempus AI to develop AI tools for drug development in Alzheimer’s disease and other neurological disorders. Alongside the partnership, Pathos raised $237 million in a Series E round led by Bristol Myers Squibb, valuing the company at approximately $3 billion. Tempus will assemble a dataset drawn from hundreds of thousands of patients with neurological disorders, while Pathos plans to use its Pathos Foundry platform to study disease biology and generate testable hypotheses. The partners aim to support more targeted clinical-trial design, although clinical benefits have not yet been established. 🧠 WHAT CAN IT DO? Pathos Foundry is designed to analyse large biomedical datasets, identify patterns linked to disease and generate hypotheses for researchers to test. Combined wi...
